Skip to content

Analgesic Effect of Supraclavicular Block and Interscalene Analgesia Versus an Intercostobrachial Nerve Block Versus PCA in Forearm Surgery

Efficacy of Combined US-Guided Supraclavicular Block and Interscalene Analgesia Versus an Intercostobrachial Nerve Block Versus PCA With Fentanyl on Preventing Tourniquet Pain in Forearm Surgery: A Randomized Clinical Trial

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05602636
Enrollment
60
Registered
2022-11-02
Start date
2022-12-10
Completion date
2025-12-30
Last updated
2026-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Forearm Surgery, Interscalene Analgesia, Tourniquet Pain, US-Guided Supraclavicular Block

Keywords

Intercostobrachial Nerve Block, PCA with Fentanyl

Brief summary

The etiology of tourniquet pain is complex, and the study team hypothesizes that blocking with Interscalene brachial plexus block (ISBPB) is more efficient in decreasing the incidence of tourniquet pain in comparison with other techniques. As there is a paucity of studies that evaluate the effect of intercostobrachial nerve (ICBN) block and ISBPB and Patient-Controlled Analgesia (PCA) with a supraclavicular brachial plexus block (SCBPB) on tourniquet pain in forearm surgery, Therefore, we established this randomized study to compare ISBPB and ICBN and PCA with fentanyl with SCBPB in terms of the incidence and severity of tourniquet pain in patients undergoing forearm surgery.

Interventions

Patients will be provided with midazolam (up to 2 mg) if requested. No opioids will be administered before the incision. At the first patient complaint of pain, the intraoperative anesthesia team will document the quality and location of pain, and 50 microgram of fentanyl will be administered if the patient requested it or pain score more than 3

Sponsors

Al-Azhar University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* aged more than 18 years, * ASAI-III patients * scheduled to undergo orthopedic or plastic surgery distal to the elbow with an anticipated tourniquet duration greater than 45 min. * desiring regional anesthesia as the primary anesthetic.

Exclusion criteria

* Contraindication to regional anesthesia. * Allergy to local anesthetics. * Primary block failure. * If patients desired deep intraoperative sedation. * Clinically significant cognitive impairment.

Design outcomes

Primary

MeasureTime frameDescription
The incidence of tourniquet pain2 hoursThe incidence of tourniquet pain will be assessed by the patient's VAS score. The Visual Analogue Scale (VAS) measures pain intensity. The VAS consists of a 10cm line, with two end points representing 0 ('no pain') and 10 ('pain as bad as it could possibly be'). The patient is asked to rate their current level of pain by placing a mark on the line.

Secondary

MeasureTime frameDescription
Hemodynamics2 hoursHemodynamics up to 2 hours postoperative (heart rate, mean arterial blood pressure. Mean arterial blood pressure and heart rate will be recorded at baseline and every 5 min till the end of the procedure.
The incidence of adverse reactions2 hoursThe incidence of adverse reactions (Pneumothorax, Horner's syndrome) will be evaluated.
Patients' satisfaction24 hoursPatients' satisfaction will be measured immediately postoperative and after 24 hours using a five-point Likert scale consisting of very dissatisfied, dissatisfied, unsure, satisfied, and very satisfied.

Countries

Egypt

Contacts

Primary ContactNeveen A. Kohaf, Ph.D
nevenabdo@azhar.edu.eg+201069482380

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026